Evaluating the Effectiveness of Miner Blocker Browser Extensions

JavaScript crypto miners have been around for quite a while. Monero (XMR), the crypto currency mined by these scripts was released in April 2014. As shown in the following figure, the increase in price of Bitcoin was coupled with increase in price of Ethereum and Monero. This jump led to these in browser miners being over emphasized in the media. Advertisements being replaced by miners Website administrators started including miner scripts in their websites. The more the user stays on the website, the more Monero mined. Coinhive review: Embeddable JavaScript Crypto Miner – 3 days in [1] shows that using...

Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study - The Lancet Respiratory Medicine

Release Notes for Learn SaaS

Evaluation of plasma-activated water: Efficacy, stability, physicochemical properties, and mechanism of inactivation against Escherichia coli - ScienceDirect

What is CRISP DM? - Data Science Process Alliance

Development of the Indian Reference Case for undertaking economic evaluation for health technology assessment - The Lancet Regional Health - Southeast Asia

Biochar preparation and evaluation of its effect in composting mechanism: A review - ScienceDirect

Evaluating and mitigating the potential indirect effect of COVID-19 on control programmes for seven neglected tropical diseases: a modelling study - The Lancet Global Health

Applied Sciences, Free Full-Text

minerBlock – Get this Extension for 🦊 Firefox (en-US)

What is Browser Fingerprinting - How Does It Work?

IJMS, Free Full-Text

Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial - The Lancet Diabetes & Endocrinology

minerBlock extension - Opera add-ons

25 Best Chrome Extensions To Protect Your Privacy

Design and Rationale of the APPELHUS Phase 3 Open-Label Study of Factor B Inhibitor Iptacopan for Atypical Hemolytic Uremic Syndrome - ScienceDirect